Zura Bio (ZURA) 2025 Conference September 04, 2025 02:45 PM ET Speaker2Alright, we're ready to get started. Welcome, everyone, and thanks for tuning in. This is Josh Schimmer from the Cantor Biotech Equity Research Team, joined by Mai Ringer in hidradenitis suppurativa, Imogen Mansfield, who's done extensive work in understanding this disease. Together, we're welcoming Zura Bio, Robert Lisicki, Chief Executive Officer. Robert, welcome. Maybe start with a snapshot of the company and your lead program tibuliz ...

Forward Looking Statements Disclaimer This communication includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believe," "predict," "potential," "continue," "strategy," "future," "opportunity," "would," "seem," "seek," "outlook" and the negatives of such terms and similar expressions ...